Efficacy of zinc supplementation for treatment of primary dysmenorrhoea among senior secondary students in Alor South-East Nigeria: A double-blind randomized controlled study

ZOFT Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202105843292338

Enrollment

100

Registered

2021-05-25

Start date

2021-04-07

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea

Interventions

Zinc group

Placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Ages between 13-21 Regular menses Has ability to score pain using a 10cm visual analog scale

Exclusion criteria

Exclusion criteria: Students with other gynaecological disease Those with secondary dysmenorrhoea Those with a history of chronic illness Those with adverse reaction to zinc Those on hormonal medications or herbal medications Those who refuse to participate

Design outcomes

Primary

Measure	Time frame
Mean visual analog score for three cycles ;Proportion with nausea and vomiting	—

Secondary

Measure	Time frame
Additional analgesics;Allergic reaction	—

Countries

Nigeria

Contacts

Public ContactIfeanyi Okonkwo

Senior Registrar

Exajay@yahoo.co.uk08034095756

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 9, 2026